Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mankind Pharma Gets DRDO Nod to Manufacture, Market Covid Drug 2-DG
Details : 2-DG (2-deoxy-D-glucose) is approved and is indicated as an adjunct treatment for patienst siffering from moderate to severe Covid-19.
Product Name : 2-DG
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 08, 2021
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dr. Reddy’s Laboratories Announces Commercial Launch of 2DG
Details : 2-deoxy-D-glucose (2-DG), reduces the multiplicity of the SARS-CoV-2 virus, alleviates cells from infection-induced cytopathic effect (CPE) and cell death. 2-DG manufactured by Dr. Reddy’s has a purity of 99.5% and is being sold commercially under the ...
Product Name : 2-DG
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 28, 2021
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Lee Pharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
CSIR-IICT Licenses Process Knowhow for Synthesis of 2-Deoxy-D-Glucose to Lee Pharma Ltd.
Details : Indian Institute of Chemical Technology, (IICT) and Lee Pharma have entered into a non-exclusive licensing agreement for the synthesis of 2-Deoxy-D-Glucose (2-DG). Lee Pharma would file the application for getting the approval from DCGI and will manufact...
Product Name : 2-DG
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
September 06, 2021
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Lee Pharma
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : BDR Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
BDR Pharma Inks License Agreement with DRDO to Produce COVID-19 Drug 2-DG
Details : BDR Pharma has inked a pact with the Defence Research and Development Establishment (DRDE) and the Institute of Nuclear Medicine and Allied Sciences (INMAS) of the DRDO for manufacturing, distribution, and marketing of 2-DG in the country.
Product Name : 2-DG
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
July 26, 2021
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : BDR Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Reset All
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
